Sarah Parisi

1.4k total citations
59 papers, 826 citations indexed

About

Sarah Parisi is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Sarah Parisi has authored 59 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hematology, 15 papers in Molecular Biology and 15 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Sarah Parisi's work include Acute Myeloid Leukemia Research (28 papers), Acute Lymphoblastic Leukemia research (15 papers) and Hematopoietic Stem Cell Transplantation (10 papers). Sarah Parisi is often cited by papers focused on Acute Myeloid Leukemia Research (28 papers), Acute Lymphoblastic Leukemia research (15 papers) and Hematopoietic Stem Cell Transplantation (10 papers). Sarah Parisi collaborates with scholars based in Italy, United Kingdom and South Korea. Sarah Parisi's co-authors include Antonio Curti, Stefania Paolini, Giovanni Martinelli, Loredana Ruggeri, Elena Urbani, Carlo Finelli, Alessandro Isidori, Sara Trabanelli, Michele Baccarani and Darina Očadlíková and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Sarah Parisi

55 papers receiving 817 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah Parisi Italy	15	431	395	326	221	112	59	826
Astrid Olsnes Kittang Norway	16	240 0.6×	530 1.3×	141 0.4×	278 1.3×	157 1.4×	30	790
Maria Askmyr Sweden	12	203 0.5×	392 1.0×	206 0.6×	311 1.4×	126 1.1×	23	810
Rana Baraz Australia	10	185 0.4×	237 0.6×	174 0.5×	227 1.0×	67 0.6×	13	559
Jessica McLeod Canada	7	339 0.8×	534 1.4×	150 0.5×	533 2.4×	117 1.0×	21	977
Bruno A. Cardoso Portugal	14	234 0.5×	250 0.6×	230 0.7×	434 2.0×	120 1.1×	25	858
Chelsea Malter United States	8	396 0.9×	265 0.7×	101 0.3×	281 1.3×	58 0.5×	8	714
Anand Jillella United States	12	136 0.3×	379 1.0×	166 0.5×	456 2.1×	113 1.0×	48	841
C. Matthias Wilk Switzerland	11	159 0.4×	250 0.6×	144 0.4×	131 0.6×	113 1.0×	29	516
Christian Hurtz United States	10	151 0.4×	258 0.7×	115 0.4×	246 1.1×	107 1.0×	32	607
José‐Marc Techner United States	5	462 1.1×	380 1.0×	78 0.2×	223 1.0×	118 1.1×	8	756

Countries citing papers authored by Sarah Parisi

Since Specialization

Citations

This map shows the geographic impact of Sarah Parisi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Parisi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Parisi more than expected).

Fields of papers citing papers by Sarah Parisi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Parisi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Parisi. The network helps show where Sarah Parisi may publish in the future.

Co-authorship network of co-authors of Sarah Parisi

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Parisi. A scholar is included among the top collaborators of Sarah Parisi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Parisi. Sarah Parisi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Finelli, Carlo, Antonio Curti, Stefania Paolini, et al.. (2024). Signaling pathways and bone marrow microenvironment in myelodysplastic neoplasms. Advances in Biological Regulation. 95. 101071–101071. 2 indexed citations

Meazza, Raffaella, Loredana Ruggeri, Fabio Guolo, et al.. (2023). Donor selection for adoptive immunotherapy with NK cells in AML patients: Comparison between analysis of lytic NK cell clones and phenotypical identification of alloreactive NK cell repertoire. Frontiers in Immunology. 14. 1111419–1111419. 7 indexed citations

Mongiorgi, Sara, Stefano Ratti, Valentina Indio, et al.. (2023). A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes. Clinical Epigenetics. 15(1). 27–27. 3 indexed citations

Sartor, Chiara, Mario Arpinati, Gabriella Chirumbolo, et al.. (2022). Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment. Hematological Oncology. 40(4). 734–742. 4 indexed citations

Parisi, Sarah & Carlo Finelli. (2021). Prognostic Factors and Clinical Considerations for Iron Chelation Therapy in Myelodysplastic Syndrome Patients. Journal of Blood Medicine. Volume 12. 1019–1030. 7 indexed citations

Nanni, Jacopo, Chiara Sartor, Sarah Parisi, et al.. (2021). Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement. Acta Haematologica. 144(6). 688–692.

Finelli, Carlo & Sarah Parisi. (2020). The clinical impact of COVID-19 epidemic in the hematologic setting. Advances in Biological Regulation. 77. 100742–100742. 12 indexed citations

Follo, Matilde Y., Andrea Pellagatti, Richard N. Armstrong, et al.. (2019). Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes. Leukemia. 33(9). 2276–2290. 22 indexed citations

Corradi, Giulia, Carmen Baldazzi, Darina Očadlíková, et al.. (2018). Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival. Stem Cell Research & Therapy. 9(1). 271–271. 69 indexed citations

10.

Nanni, Jacopo, Giorgia Simonetti, Giovanni Marconi, et al.. (2017). A Three-Genes Signature of Anti-Apoptotic Genes Showed Different Mechanisms in Preventing Apoptosis in Acute Myeloid Leukemia Cells and Could Provide an Useful Model to Establish the Proper BH3-Mimetich Drug or Combination. Blood. 130. 4969–4969. 1 indexed citations

11.

Benedittis, Caterina De, Cristina Papayannidis, Claudia Venturi, et al.. (2017). The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report. BMC Cancer. 17(1). 523–523. 1 indexed citations

12.

Isidori, Alessandro, Federica Loscocco, Marilena Ciciarello, et al.. (2016). Renewing the immunological approach to AML treatment: from novel pathways to innovative therapies. 2(2). 226–251. 2 indexed citations

13.

Finelli, Carlo, Matilde Y. Follo, Marta Stanzani, et al.. (2016). Clinical Impact of Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes. Current Pharmaceutical Design. 22(16). 2349–2357. 13 indexed citations

14.

Lemoli, Roberto M., Sarah Parisi, & Antonio Curti. (2016). Novel strategies of adoptive immunotherapy: How natural killer cells may change the treatment of elderly patients with acute myeloblastic leukemia. Experimental Hematology. 45. 10–16. 3 indexed citations

15.

Iacobucci, Ilaria, Annalisa Lonetti, Claudia Venturi, et al.. (2014). Use of a high sensitive nanofluidic array for the detection of rare copies of BCR-ABL1 transcript in patients with Philadelphia-positive acute lymphoblastic leukemia in complete response. Leukemia Research. 38(5). 581–585. 18 indexed citations

16.

Isidori, Alessandro, Valentina Salvestrini, Marilena Ciciarello, et al.. (2014). The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment. Expert Review of Hematology. 7(6). 807–818. 60 indexed citations

17.

Trabanelli, Sara, Darina Očadlíková, Cecilia Evangelisti, Sarah Parisi, & Antonio Curti. (2011). Induction of Regulatory T Cells by Dendritic Cells through Indoleamine 2,3- dioxygenase: A Potent Mechanism of Acquired Peripheral Tolerance. Current Medicinal Chemistry. 18(15). 2234–2239. 22 indexed citations

18.

Papayannidis, Cristina, Ilaria Iacobucci, Maria Chiara Abbenante, et al.. (2010). Complete paraplegia after Nelarabine treatment in a T‐cell acute lymphoblastic leukemia adult patient. American Journal of Hematology. 85(8). 608–608. 26 indexed citations

19.

Piccaluga, Pier Paolo, F. Bacci, Elena Sabattini, et al.. (2009). Large cell non Hodgkin’s lymphoma: what is new in the WHO classification?. 3(3). 43–45.

20.

Basile, Marco, et al.. (1984). Somatostatin in the treatment of severe gastrointestinal bleeding from peptic origin. A multicentric controlled trial.. PubMed. 14(1). 31–5. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact